TFO
ALBO

Tarbox Family Office’s Albireo Pharma Inc ALBO Stock Holding History

Tarbox Family Office’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-50
Closed -$1K – 1071
2022
Q1 		$1K Hold
50
– – ﹤0.01% 1054
2021
Q4 		$1K Hold
50
– – ﹤0.01% 1098
2021
Q3 		$2K Hold
50
– – ﹤0.01% 992
2021
Q2 		$2K Hold
50
– – ﹤0.01% 1005
2021
Q1 		$2K Hold
50
– – ﹤0.01% 969
2020
Q4 		$2K Hold
50
– – ﹤0.01% 929
2020
Q3 		$2K Hold
50
– – ﹤0.01% 876
2020
Q2 		$1K Hold
50
– – ﹤0.01% 1114
2020
Q1 		$1K Buy
+50
New +$1.1K ﹤0.01% 1052

Other funds holding ALBO

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
DCMIC
Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return

Tarbox Family Office's ALBO Position: Q2 2022 in Review

Tarbox Family Office sold out of Albireo Pharma Inc (ALBO) in Q2 2022, closing a stake of 50 shares — an estimated $1K sold.

Tarbox Family Office first reported a position in ALBO in Q1 2020 and held it in 9 quarters. The position peaked at $2K in Q3 2021. 103 funds tracked by Wall St. Rank hold ALBO as of Q2 2022.

  • Tarbox Family Office reported no remaining Albireo Pharma Inc position as of Q2 2022 after selling out during the quarter.
  • Tarbox Family Office sold 50 Albireo Pharma Inc shares in Q2 2022, an estimated $1K.
  • Tarbox Family Office first reported a position in Albireo Pharma Inc in Q1 2020 and held it in 9 quarters.
  • Tarbox Family Office's Albireo Pharma Inc position peaked at $2K in Q3 2021.
  • 103 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q2 2022.

Based on Tarbox Family Office's 13F filing for Q2 2022, filed 19 Jul 2022.